These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26947456)

  • 1. Comparing the epidemiology of hospital-acquired methicillin-resistant Staphylococcus aureus clone groups in Alberta, Canada.
    Bruzzese S; Bush K; Leal J; Kim J; Vickers DM; Rusk A; Fathima S; Li V; Chui L; Louie M; Henderson E
    Epidemiol Infect; 2016 Jul; 144(10):2184-90. PubMed ID: 26947456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of new CMRSA7/USA400 methicillin-resistant Staphylococcus aureus spa types in Alberta, Canada, from 2005 to 2012.
    Li V; Chui L; Simmonds K; Nguyen T; Golding GR; Yacoub W; Ferrato C; Louie M
    J Clin Microbiol; 2014 Jul; 52(7):2439-46. PubMed ID: 24789179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular epidemiology of incident methicillin-resistant Staphylococcus aureus cases among hospitalized patients in Alberta, Canada: a retrospective cohort study.
    Bush K; Leal J; Fathima S; Li V; Vickers D; Chui L; Louie M; Taylor G; Henderson E
    Antimicrob Resist Infect Control; 2015; 4():35. PubMed ID: 26380079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic and geospatial associations with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in a large Canadian city: an 11 year retrospective study.
    Gill VC; Ma I; Guo M; Gregson DB; Naugler C; Church DL
    BMC Public Health; 2019 Jul; 19(1):914. PubMed ID: 31288765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada.
    Nichol KA; Adam HJ; Roscoe DL; Golding GR; Lagacé-Wiens PR; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i47-55. PubMed ID: 23587778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.
    Nichol KA; Adam HJ; Hussain Z; Mulvey MR; McCracken M; Mataseje LF; Thompson K; Kost S; Lagacé-Wiens PR; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):320-5. PubMed ID: 21353960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National surveillance of methicillin-resistant Staphylococcus aureus among hospitalized pediatric patients in Canadian acute care facilities, 1995-2007.
    Matlow A; Forgie S; Pelude L; Embree J; Gravel D; Langley JM; Saux NL; Moore D; Mounchili A; Mulvey M; Shurgold J; Simor AE; Thomas E; Vayalumkal J;
    Pediatr Infect Dis J; 2012 Aug; 31(8):814-20. PubMed ID: 22565289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Update of Phenotypic Prediction Rule for Methicillin-Resistant Staphylococcus aureus (MRSA) USA300 Discloses Jail Transmission Networks with Increased Resistance.
    Sansom SE; Benedict E; Thiede SN; Hota B; Aroutcheva A; Payne D; Zawitz C; Snitkin ES; Green SJ; Weinstein RA; Popovich KJ
    Microbiol Spectr; 2021 Sep; 9(1):e0037621. PubMed ID: 34287060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007.
    Hultén KG; Kaplan SL; Lamberth LB; Slimp K; Hammerman WA; Carrillo-Marquez M; Starke JR; Versalovic J; Mason EO
    Infect Control Hosp Epidemiol; 2010 Feb; 31(2):183-90. PubMed ID: 20001603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of MRSA in Canada from 2007 to 2016.
    Nichol KA; Adam HJ; Golding GR; Lagacé-Wiens PRS; Karlowsky JA; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv55-iv63. PubMed ID: 31505646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections.
    Moore CL; Hingwe A; Donabedian SM; Perri MB; Davis SL; Haque NZ; Reyes K; Vager D; Zervos MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):148-55. PubMed ID: 19394801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Alberta, Canada: population-based surveillance, 2005-2008.
    Kim J; Ferrato C; Golding GR; Mulvey MR; Simmonds KA; Svenson LW; Keays G; Chui L; Lovgren M; Louie M
    Epidemiol Infect; 2011 Jul; 139(7):1009-18. PubMed ID: 20854711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of hospital-onset methicillin-resistant Staphylococcus aureus infections in Southern Chile.
    Medina G; Egea AL; Otth C; Otth L; Fernández H; Bocco JL; Wilson M; Sola C
    Eur J Clin Microbiol Infect Dis; 2013 Dec; 32(12):1533-40. PubMed ID: 23765159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in genotype of methicillin-resistant Staphylococcus aureus (MRSA) affects the antibiogram of hospital-acquired MRSA.
    Harada D; Nakaminami H; Miyajima E; Sugiyama T; Sasai N; Kitamura Y; Tamura T; Kawakubo T; Noguchi N
    J Infect Chemother; 2018 Jul; 24(7):563-569. PubMed ID: 29628385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of methicillin-resistant Staphylococcus aureus isolated from tertiary care hospitals in Tokyo, Japan.
    Nakaminami H; Noguchi N; Ito A; Ikeda M; Utsumi K; Maruyama H; Sakamoto H; Senoo M; Takasato Y; Nishinarita S
    J Infect Chemother; 2014 Aug; 20(8):512-5. PubMed ID: 24767464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.
    Jenkins TC; McCollister BD; Sharma R; McFann KK; Madinger NE; Barron M; Bessesen M; Price CS; Burman WJ
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):233-41. PubMed ID: 19199535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics, virulence factors and molecular typing of methicillin-resistant Staphylococcus aureus infections in Shenzhen City, China.
    Hu L; Li Y; Lu Y; Klena JD; Qiu Y; Lin Y; Jiang M; Shi X; Chen L; Liu X; Ma H; Cheng J; Wu S; Kan B; Hu Q
    Epidemiol Infect; 2016 Oct; 144(14):3037-3045. PubMed ID: 27447826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissemination of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus USA300 clone in multiple hospitals in Tokyo, Japan.
    Takadama S; Nakaminami H; Sato A; Shoshi M; Fujii T; Noguchi N
    Clin Microbiol Infect; 2018 Nov; 24(11):1211.e1-1211.e7. PubMed ID: 29454850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular epidemiology of community-acquired, healthcare-associated and nosocomial methicillin-resistant Staphylococus aureus in Spain.
    Rodríguez-Baño J; Angeles Domínguez M; Blas Millán A; Borraz C; Pau González M; Almirante B; Cercenado E; Padilla B; Pujol M; ;
    Clin Microbiol Infect; 2009 Dec; 15(12):1111-8. PubMed ID: 19456840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal diversity and epidemiological characteristics of Staphylococcus aureus: high prevalence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) associated with clinical isolates in Brazil.
    Andrade-Figueiredo M; Leal-Balbino TC
    BMC Microbiol; 2016 Jun; 16(1):115. PubMed ID: 27325108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.